JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
159 hedge funds and large institutions have $1.27B invested in Juno Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 60 increasing their positions, 43 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
31% less call options, than puts
Call options by funds: $18.7M | Put options by funds: $27M
36% less capital invested
Capital invested by funds: $1.97B → $1.27B (-$701M)
Holders
159
Holding in Top 10
3
Calls
$18.7M
Puts
$27M
Top Buyers
| 1 | +$33.5M | |
| 2 | +$14.8M | |
| 3 | +$9.01M | |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$8.77M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$6.77M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$18.9M | |
| 3 | -$14.8M | |
| 4 |
BAMCO Inc
New York
|
-$13.3M |
| 5 |
CCI
Columbus Circle Investors
|
-$4.22M |